Melanoma

Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
Hiroyuki Kishi, Hiroshi Hamana, Kiyomi Shitaoka, Atsushi Muraguchi

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P74; DOI: 10.1186/2051-1426-3-S2-P74
Preclinical to clinical translation of anti-PD-1 blockade
Heather Hirsch, Elaine Pinheiro, Mark Ayers, Jared Lunceford, Michael Nebozhyn, Erin Murphy, Mingmei Cai, Yanhong Ma, Manjiri Sathe, Terri McClanahan

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P92; DOI: 10.1186/2051-1426-3-S2-P92
Prevalence analysis of OX40-positive cell populations in solid tumors
James Ziai, Gretchen Frantz, Liping Zhang, Cleopatra Kozlowski, Houston Gilbert, Jacquelyn Smith, Marcin Kowanetz, Jeong M Kim, Mahrukh Huseni

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P113; DOI: 10.1186/2051-1426-3-S2-P113
Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
Antonio Maria Grimaldi, Ester Simeone, Lucia Festino, Diana Giannarelli, Marco Palla, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Maria Chiara Grimaldi, Nicola Mozzillo, Paolo A Ascierto

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P186; DOI: 10.1186/2051-1426-3-S2-P186
Virus-specific CD8+ T cells infiltrate melanoma lesions and retain function despite high PD-1 expression
Dan A Erkes, Toktam Mohgbeli, Christopher M Snyder

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) O6; DOI: 10.1186/2051-1426-3-S2-O6
Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control
Krit Ritthipichai, Cara Haymaker, Yared Hailemichael, Minying Zhang, Roza Nurieva, Patrick Hwu, Chantale Bernatchez

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P46; DOI: 10.1186/2051-1426-3-S2-P46
High Th17:Treg ratio may predict complete response to HDIL-2 in the setting of melanoma
Maggie L Diller, Ford Mandy, Keith A Delman, David H Lawson

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P297; DOI: 10.1186/2051-1426-3-S2-P297
Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
Marit M Melssen, Ciara Hutchison, Ileana S Mauldin, Timothy N Bullock, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P235; DOI: 10.1186/2051-1426-3-S2-P235
Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
Jessica S Crystal, Todd D Prickett, Jared J Gartner, Maria R Parkhurst, Yong-Chen Lu, Alena Gros, Yong Li, Kasia Trebska-Mcgowan, Mona El-Gamil, Steven A Rosenberg, Paul F Robbins

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P9; DOI: 10.1186/2051-1426-3-S2-P9
Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON
Zhiwei Hu, Elizabeth McMichael, Amanda Campbell, Cheryl A London, William E Carson

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P304; DOI: 10.1186/2051-1426-3-S2-P304

Main menu

Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma

Pages